GTBP
GT Biopharma·NASDAQ
--
--(--)
--
--(--)
GTBP Filings
Filing Date
Form Description
Form Type
2026-02-02
Form EFFECT - Notice of Effectiveness
2026-02-02 ·
Form EFFECT - Notice of Effectiveness
2026-01-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-21
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-21 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-08
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-08 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-03
Form EFFECT - Notice of Effectiveness
2025-12-03 ·
Form EFFECT - Notice of Effectiveness
2025-12-02
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-02 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-26
Form 8-K - Current report
Key Events
2025-11-26 · Key Events
Form 8-K - Current report
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-10-24
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-10-24 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
